FOLD – amicus therapeutics, inc. (US:NASDAQ)
Stock Stats
News
1/9
07:03 pm
fold
Low
Assessing Amicus Therapeutics (FOLD) Valuation After Recent Share Price Momentum [Yahoo! Finance]
1/9
04:31 am
fold
Low
Is Amicus Therapeutics (FOLD) Pricing Reflect Recent 45% Surge And DCF Upside Potential [Yahoo! Finance]
1/8
12:49 pm
fold
Low
Halper Sadeh LLC Encourages THS, FOLD, REVG Shareholders to Contact the Firm to Discuss Their Rights
1/6
07:25 am
fold
Low
Amicus Therapeutics (NASDAQ:FOLD) was downgraded by analysts at Guggenheim from a "strong-buy" rating to a "hold" rating.
12/29
08:00 am
fold
Low
Amicus Therapeutics (NASDAQ:FOLD) was downgraded by analysts at Leerink Partners from an "outperform" rating to a "market perform" rating. They now have a $14.50 price target on the stock.
11/4/2025
07:00 am
FOLD
-1.2%
BEAT
7/31/2025
07:00 am
FOLD
-6.4%
BEAT
5/1/2025
07:00 am
FOLD
-9.7%
BEAT
2/19/2025
07:00 am
FOLD
-4.3%
BEAT
1/6
07:25 am
Downgrades
Strong-Buy
Hold
Guggenheim
Low
0.2%
1/6
07:25 am
Downgrades
Strong-Buy
Hold
Guggenheim
Low
0.2%
1/5
09:24 am
Downgrades
BUY
NEUTRAL
GUGGENHEIM
0.0%
1/5
09:24 am
Downgrades
BUY
NEUTRAL
GUGGENHEIM
0.0%
12/29
08:52 am
Downgrades
Outperform
Market Perform
Leerink Partners
Low
0.1%
1/6
07:48 pm
fold
Low
Form 4 AMICUS THERAPEUTICS, For: Jan 02 Filed by: Rosenberg Ellen
1/6
07:47 pm
fold
Low
Form 4 AMICUS THERAPEUTICS, For: Jan 02 Filed by: Castelli Jeff
1/6
07:46 pm
fold
Low
Form 4 AMICUS THERAPEUTICS, For: Jan 02 Filed by: Prout Samantha
1/6
07:45 pm
fold
Low
Form 4 AMICUS THERAPEUTICS, For: Jan 02 Filed by: Clark David Michael
12/30
06:05 pm
fold
Low
Form 4 AMICUS THERAPEUTICS, For: Dec 26 Filed by: Harford Simon N.R.
Show more
Top News Gainers
4/2 Amicus Therapeutics, Inc. (NASDAQ: FOLD) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 8.5%
2/4 Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $20.00 price target on the stock, up previously from $19.00. 7.0%
3/9 Form 4 AMICUS THERAPEUTICS, For: Mar 05 Filed by: Campbell Bradley L 6.9%
2/4 Form 4 AMICUS THERAPEUTICS, For: Jan 31 Filed by: Crowley John F 6.5%
6/17 Amicus Therapeutics, Inc. (NASDAQ: FOLD) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock. 5.8%
1/14 Form 4 AMICUS THERAPEUTICS, For: Jan 10 Filed by: Barth Jay 5.4%
10/3 Is Amicus Therapeutics, Inc. (NASDAQ:FOLD) A Volatile Stock? [Yahoo! Finance News] 4.8%
3/24 Form 4 AMICUS THERAPEUTICS, For: Mar 20 Filed by: Crowley John F 4.4%
7/17 Amicus Therapeutics, Inc. (NASDAQ: FOLD) was given a new $18.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock. 4.4%
4/24 Amicus Therapeutics to Announce First Quarter 2020 Financial Results on May 7, 2020 4.3%
Top News Decliners
10/3 Amicus snaps back on positive data from Pompe Disease study of AT-GAA [Seeking Alpha] -10.0%
8/2 Amicus Therapeutics Receives Marketing Authorization for Galafold® (migalastat) for Fabry Disease in Argentina -9.0%
3/2 Amicus Therapeutics Announces Full-Year 2019 Financial Results and 2020 Corporate Updates -8.4%
8/8 Amicus Therapeutics, Inc. (FOLD) CEO John Crowley on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] -7.5%
5/29 Amicus Therapeutics Announces Public Offering of Common Stock -7.2%
12/4 Form 4 AMICUS THERAPEUTICS, For: Dec 02 Filed by: Crowley John F -6.8%
8/8 Q2/2019 6/30/2019 EPS -0.360 ZacksConsensus -0.340 ActVsEst (0.020) - Miss -6.7%
7/4 Why Amicus Therapeutics' Stock Perked Up in June [The Motley Fool] -6.2%
1/18 Amicus Therapeutics, Inc. (NASDAQ: FOLD) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -6.0%
1/13 Form 8-K AMICUS THERAPEUTICS, For: Jan 13 -5.7%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3